CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | Hornung William Karl Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +80,069 | 80,069 | ||
| 2020-11-17 | ELDER WILLIAM ROBERT GC & Secretary | Purchase | +5,000 | $0.63 | $3K | 15,000 |
| 2020-11-16 | Cobuzzi Robert Joseph Jr. President & CEO | Purchase | +14,000 | $0.66 | $9K | 14,000 |
| 2020-11-16 | ELDER WILLIAM ROBERT GC & Secretary | Purchase | +10,000 | $0.67 | $7K | 10,000 |
| 2020-10-19 | GALLOWAY CHRISTOPHER D Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2020-09-22 | ELDER WILLIAM ROBERT GC & Secretary | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2020-09-08 | Cobuzzi Robert Joseph Jr. President & CEO | Grant or award · Stock Option (Right to Buy) | +475,000 | 475,000 | ||
| 2020-09-01 | Hollingsworth Jane H Director | Grant or award · Stock Option (Right to Buy) | +67,400 | 67,400 | ||
| 2020-09-01 | Hollingsworth Jane H Director | Grant or award · Restricted Stock Unit | +54,900 | 54,900 | ||
| 2020-06-17 | Adams Robert W Director | Grant or award · Stock Option (Right to Buy) | +61,300 | 61,300 | ||
| 2020-06-17 | Cobuzzi Robert Joseph Jr. Director | Grant or award · Stock Option (Right to Buy) | +61,300 | 61,300 | ||
| 2020-06-17 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +61,300 | 61,300 | ||
| 2020-06-17 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +61,300 | 61,300 | ||
| 2020-01-07 | Cobuzzi Robert Joseph Jr. Director | Grant or award · Stock Option (Right to Buy) | +118,600 | 118,600 | ||
| 2020-01-07 | Cobuzzi Robert Joseph Jr. Director | Grant or award · Restricted Stock Unit | +98,100 | 98,100 | ||
| 2020-01-07 | Byrne Thomas E General Counsel | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2020-01-02 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +239,400 | 239,400 | ||
| 2020-01-02 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +262,900 | 262,900 | ||
| 2020-01-02 | Hornung William Karl Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +52,600 | 52,600 | ||
| 2019-06-13 | Adams Robert W Director | Grant or award · Stock Option (Right to Buy) | +19,200 | 19,200 |
Page 9 of 17 · 321 trades